Skip to content

Insider · CIK 0001489798

Janet Dillione

director

Files at CRMD (CorMedix Inc.). First filing Nov 18, 2025, latest Dec 11, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $1.5M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CRMD: CorMedix Inc.

CRMDOct 9, 2026 · close 7.38

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
21Weak
CRMDsell 310b5-1
CorMedix Inc.
$408k
34,000 shares
-41%+98% from low-30% from high
15Weak
CRMDsell 210b5-1
CorMedix Inc.
$467k
46,657 shares
-49%+67% from low-41% from high
23Weak
CRMDsell
CorMedix Inc.
$262k
26,343 shares
-35%+68% from low-41% from high
40Moderate
CRMDsell
CorMedix Inc.
$343k
30,000 shares
-38%+92% from low-32% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 18, 2026CRMD
CorMedix Inc.
MOption exercise
Common Stock
+48,909--117,83524 d ago
Sep 18, 2026CRMD
CorMedix Inc.
MOption exercise
Phantom Stockderivative
-48,909--024 d ago
Dec 9, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock10b5-1
+19,000$9.55$181k67,473Dec 11, 2025
Dec 9, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock10b5-1
+15,000$5.63$84k82,473Dec 11, 2025
Dec 9, 2025CRMD
CorMedix Inc.
SOpen-market sale
Common Stock10b5-1
-34,000$12.00$408k48,473Dec 11, 2025
Dec 9, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative10b5-1
-19,000$0.00$00Dec 11, 2025
Dec 9, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative10b5-1
-15,000$0.00$00Dec 11, 2025
Dec 2, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock10b5-1
+12,210$4.03$49k60,683Dec 4, 2025
Dec 2, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock10b5-1
+15,124$4.43$67k75,807Dec 4, 2025
Dec 2, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock10b5-1
+19,323$3.55$69k95,130Dec 4, 2025
Dec 2, 2025CRMD
CorMedix Inc.
SOpen-market sale
Common Stock10b5-1
-46,657$10.00$467k48,473Dec 4, 2025
Dec 2, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative10b5-1
-12,210$0.00$00Dec 4, 2025
Dec 2, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative10b5-1
-15,124$0.00$00Dec 4, 2025
Dec 2, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative10b5-1
-19,323$0.00$05,000Dec 4, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock
+8,000$2.85$23k56,473Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock
+7,790$4.03$31k64,263Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock
+4,876$4.43$22k69,139Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Common Stock
+5,677$3.55$20k74,816Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
SOpen-market sale
Common Stock
-26,343$9.93$262k48,473Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative
-8,000$0.00$00Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative
-7,790$0.00$012,210Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative
-4,876$0.00$015,124Nov 26, 2025
Nov 24, 2025CRMD
CorMedix Inc.
MOption exercise
Stock Option (Right to Buy Common Stock)derivative
-5,677$0.00$024,323Nov 26, 2025
Nov 14, 2025CRMD
CorMedix Inc.
SOpen-market sale
Common Stock
-30,000$11.42$343k48,473Nov 18, 2025
Jan 17, 2025CRMD
CorMedix Inc.
AGrant or award
Common Stock
+25,000$0.00$078,473Jan 22, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Janet Dillione: insider trades and track record | InsiderTell